269 results
Page 13 of 14
8-K
EX-99.1
oxead1nyu49gf u1y7lj
26 Oct 10
Entry into a Material Definitive Agreement
12:00am
8-K
p0yeqk8ijyzh 8u
22 Oct 10
Other Events
12:00am
8-K
EX-99.1
1v7 qmly78t
22 Oct 10
Other Events
12:00am
8-K
fd3 ec5z6ouxguwzw
19 Oct 10
Completion of Acquisition or Disposition of Assets
12:00am
8-K
f37hyk zi8ynb
13 Sep 10
BioTime CEO Dr. Michael West to Present at Stem Cells USA & Regenerative Medicine Congress 2010
12:00am
8-K
EX-99.1
wzg5k5
26 Aug 10
Other Events
12:00am
8-K
y1501cu
26 Aug 10
Other Events
12:00am
8-K
fbzreh
21 Jul 10
BioTime Announces Addition of New Stem Cell Lines to Its Product Portfolio
12:00am
8-K
EX-99.1
svadb fo62
21 Jul 10
BioTime Announces Addition of New Stem Cell Lines to Its Product Portfolio
12:00am
424B3
lc6yfofcf5
5 Oct 09
Prospectus supplement
12:00am
POS AM
55frjg8q0ye8yz7lss
4 Sep 09
Prospectus update (post-effective amendment)
12:00am
POS AM
nbm1xjfolgc0 w5ca
18 Jun 09
Prospectus update (post-effective amendment)
12:00am
8-K
EX-99.1
bz27l0p24 t9w
30 Apr 09
BioTime Awarded a $4.7 Million Research Grant from the California Institute for Regenerative Medicine
12:00am
8-K
EX-99.1
hqqk0ulp brmj9l
27 Feb 09
BioTime's Subsidiary Enters Agreement Adding New Embryonic Stem Cell Lines to Its Product Portfolio
12:00am